Concert Pharmaceuticals, Inc. announced that Jesper Høiland has been appointed to its Board of Directors and will serve as a member of its Compensation Committee, effective immediately. Mr. Høiland is an industry veteran with more than 30 years of experience in the biopharmaceutical industry across numerous senior leadership roles, geographies and therapeutic areas. As President and Chief Executive Officer of Radius Health, Inc., Mr. Høiland successfully launched Radius’ first commercial product, TYMLOS™.